Skip to content
10-Q

Quarterly Report

Puramed Bioscience Inc.

0001354488-14-002872

← back to feed
Filed
May 20, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · May 13, 2014 1.07B sh
Capex Q3 2014 · Mar 31, 2014 $232
Operating Cash Flow Q3 2014 · Mar 31, 2014 −$389.66K
Operating Cash Flow Q3 2014 · Mar 31, 2013 −$958.79K
Short Term Debt Q3 2014 · Mar 31, 2014 $316.35K
Short Term Debt Q3 2014 · Jun 30, 2013 $454.03K
Stockholders Equity Q3 2014 · Mar 31, 2014 −$4.3M
Stockholders Equity Q3 2014 · Jun 30, 2013 −$2.77M
Current Liabilities Q3 2014 · Mar 31, 2014 $4.29M
Current Liabilities Q3 2014 · Jun 30, 2013 $3.17M
Current Assets Q3 2014 · Mar 31, 2014 $51.9K
Current Assets Q3 2014 · Jun 30, 2013 $326.24K
Total Assets Q3 2014 · Mar 31, 2014 $173.73K
Total Assets Q3 2014 · Jun 30, 2013 $476.35K
Sga Expense Q3 2014 · Mar 31, 2014 $142.44K
Sga Expense Q3 2014 · Mar 31, 2014 $240.09K
Sga Expense Q3 2014 · Mar 31, 2013 $83.76K
Sga Expense Q3 2014 · Mar 31, 2013 $189.87K
Net Income Q3 2014 · Mar 31, 2014 −$1.94M
Net Income Q3 2014 · Mar 31, 2014 −$3.56M
Net Income Q3 2014 · Mar 31, 2013 −$541.75K
Net Income Q3 2014 · Mar 31, 2013 −$1.64M
Operating Income Q3 2014 · Mar 31, 2014 −$1.2M
Operating Income Q3 2014 · Mar 31, 2014 −$2.12M
Operating Income Q3 2014 · Mar 31, 2013 −$410.24K
Operating Income Q3 2014 · Mar 31, 2013 −$1.33M
Gross Profit Q3 2014 · Mar 31, 2014 −$3.03K
Gross Profit Q3 2014 · Mar 31, 2014 −$415.64K
Gross Profit Q3 2014 · Mar 31, 2013 −$5.22K
Gross Profit Q3 2014 · Mar 31, 2013 −$5.75K
Cost Of Revenue Q3 2014 · Mar 31, 2014 $3.03K
Cost Of Revenue Q3 2014 · Mar 31, 2014 $415.64K
Cost Of Revenue Q3 2014 · Mar 31, 2013 $5.22K
Cost Of Revenue Q3 2014 · Mar 31, 2013 $33.29K
Rd Expense Q3 2014 · Mar 31, 2013 $60.4K
Rd Expense Q3 2014 · Mar 31, 2013 $75.06K
Revenue Q3 2014 · Mar 31, 2013 $27.53K